CTC Alternative Strategies’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
CTC Alternative Strategies's BMY Position: Q2 2026 in Review
CTC Alternative Strategies opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 3,600 shares worth $207K. The stake represents 0.3% of the portfolio and ranks #78 among its holdings. This is a return to the name: CTC Alternative Strategies previously reported a position in BMY as recently as Q2 2025.
CTC Alternative Strategies first reported a position in BMY in Q2 2013 and has held it in 5 quarters since. The position peaked at $737K in Q2 2013. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- CTC Alternative Strategies held 3,600 shares of Bristol-Myers Squibb worth $207K as of Q2 2026.
- Bristol-Myers Squibb was a new CTC Alternative Strategies position in Q2 2026.
- Bristol-Myers Squibb made up 0.3% of CTC Alternative Strategies's portfolio in Q2 2026, its #78 holding.
- CTC Alternative Strategies first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 5 quarters since.
- CTC Alternative Strategies's Bristol-Myers Squibb position peaked at $737K in Q2 2013.
- 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on CTC Alternative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.